News & Articles

QIAGEN Launches Targeted RNA Panels for Next-Generation Sequencing

Multi-phase collaboration to advance next-generation sequencing, single-cell biology, and bioinformatics Sample to Insight solutions

FDA centers and researchers gain access to QIAGEN’s enhanced solutions for applications including microbial and microbiome analysis

German public health authorities turn to modern blood tests amid the influx of refugees

Record number of new projects involves start of new master collaboration with Array BioPharma

First truly end-to-end solution brings next-generation sequencing within reach for any lab

Adding solutions to QIAGEN Clinical Insight® for hereditary cancers and more somatic cancers

Enhancing and accelerating analysis and interpretation of next-generation sequencing data

therascreen® EGFR RGQ PCR Kit to guide treatment with AstraZeneca’s lung cancer drug in U.S.

Initial focus will be multiplex assays for infectious diseases on flagship automation platform

Investigator® line of DNA tests streamline investigations and reduce laboratory costs

QIAGEN And Inova Translational Medicine Institute Introduce New Database of Ethnically and Phenotypically Diverse Whole Genome Information

QIAGEN Clinical Insight® bioinformatics offering allows clinical labs to interpret and report genomic variants will be demonstrated at upcoming ClinGen, ASCO and ESHG meetings

BGI will offer QIAGEN’s Ingenuity® Variant Analysis to 10,000-plus customers, beginning in China and expanding worldwide, for seamless interpretation of sequencing data